Market closed
Bluejay Diagnostics Inc./$BJDX
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Bluejay Diagnostics Inc.
Bluejay Diagnostics Inc is a medical diagnostics company. It is developing rapid tests using whole blood using its Symphony technology platform to improve patient outcomes in critical care settings. The company's first product, the Symphony IL-6 test, is for the monitoring of disease progression in critical care settings and is a clinically established inflammatory biomarker for the assessment of the severity of infection and inflammation across many disease indications, including sepsis.
Ticker
$BJDX
Sector
Trading on
Industry
Health Care Equipment & Supplies
Headquarters
Employees
7
ISIN
US0956335097
Website
BJDX Metrics
BasicAdvanced
$986K
-
-$114.19
0.35
-
Price and volume
Market cap
$986K
Beta
0.35
52-week high
$10.20
52-week low
$1.46
Average daily volume
2.5M
Financial strength
Current ratio
6.045
Quick ratio
5.309
Long term debt to equity
2.052
Total debt to equity
4.112
Interest coverage (TTM)
-8.71%
Management effectiveness
Return on assets (TTM)
-77.76%
Return on equity (TTM)
-178.98%
Valuation
Price to book
0.17
Price to tangible book (TTM)
0.17
Price to free cash flow (TTM)
-0.04
Growth
BJDX News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Bluejay Diagnostics Inc. stock?
Bluejay Diagnostics Inc. (BJDX) has a market cap of $986K as of May 14, 2025.
What is the P/E ratio for Bluejay Diagnostics Inc. stock?
The price to earnings (P/E) ratio for Bluejay Diagnostics Inc. (BJDX) stock is 0 as of May 14, 2025.
Does Bluejay Diagnostics Inc. stock pay dividends?
No, Bluejay Diagnostics Inc. (BJDX) stock does not pay dividends to its shareholders as of May 14, 2025.
When is the next Bluejay Diagnostics Inc. dividend payment date?
Bluejay Diagnostics Inc. (BJDX) stock does not pay dividends to its shareholders.
What is the beta indicator for Bluejay Diagnostics Inc.?
Bluejay Diagnostics Inc. (BJDX) has a beta rating of 0.35. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.